RPRD2 Inhibitors
Chemical inhibitors of RPRD2 can effectively impede its function through various biochemical pathways. Staurosporine, a robust protein kinase inhibitor, directly targets the cyclin-dependent kinases (CDKs) that are essential for RPRD2's transcriptional coactivation activities. By inhibiting these CDKs, Staurosporine disrupts the phosphorylation processes vital for RPRD2 to exert its coactivating functions. Similarly, 5-Iodotubercidin, acting as an adenosine kinase inhibitor, raises intracellular adenosine levels, which can interfere with the RNA polymerase II-mediated transcription that involves RPRD2, leading to its inhibition. H-89 dihydrochloride, another kinase inhibitor, specifically inhibits protein kinase A and disrupts its regulation of transcription machinery, thereby impeding RPRD2's regulatory roles. Wortmannin and LY294002, both inhibitors of PI3K, indirectly affect RPRD2 by disrupting PI3K-dependent signaling pathways that influence transcription factor activity, which RPRD2 modulates.
SU9516 and Gö6976 also exert their inhibitory effects by targeting CDKs and protein kinases like PKC, which RPRD2 relies on for phosphorylation events in transcription regulation. By inhibiting these enzymes, SU9516 and Gö6976 prevent RPRD2 from participating in its normal regulatory roles. Roscovitine, known for its selective inhibition of CDKs, impedes the phosphorylation of RPRD2's transcriptional substrates, leading to an inhibition of its coactivation function. Indirubin-3'-monoxime extends this approach by inhibiting CDKs that phosphorylate proteins interacting with RPRD2, further inhibiting its regulatory actions. SP600125, a JNK inhibitor, disrupts the regulation of transcription factors involved in pathways that enable RPRD2 to modulate transcription. Lastly, SB203580 and PD98059 target the p38 MAP kinase and MEK respectively, both of which act on transcription factors and upstream signaling pathways that relate to RPRD2's functionality. Inhibiting these kinases leads to a decrease in the phosphorylation of transcription factors connected to RPRD2, thereby reducing the protein's ability to engage in transcriptional coactivation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. RPRD2 regulates transcriptional coactivation through cyclin-dependent kinases (CDKs). Staurosporine inhibits CDKs, leading to reduced phosphorylation and functional inhibition of RPRD2's coactivation process. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
5-Iodotubercidin is an adenosine kinase inhibitor. RPRD2 is implicated in RNA polymerase II-mediated transcription. By inhibiting adenosine kinase, this compound raises adenosine levels, which can negatively impact transcriptional processes involving RPRD2. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
H-89 is a protein kinase A inhibitor. RPRD2 interacts with the transcription machinery, which can be regulated by protein kinase A. Inhibition of this kinase can disrupt RPRD2's role in transcriptional regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor. Although RPRD2 is not directly involved in PI3K signaling, PI3K influences transcription factors and processes that RPRD2 modulates, thus indirectly inhibiting RPRD2's functional role in transcription. | ||||||
SU 9516 | 377090-84-1 | sc-222330 sc-222330A | 5 mg 25 mg | $124.00 $391.00 | 3 | |
SU9516 is a selective CDK inhibitor. Since RPRD2 functions in phosphorylation events with CDKs during transcription regulation, inhibiting CDKs can impede RPRD2's ability to participate in transcriptional coactivation. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Gö6976 is a potent inhibitor of certain protein kinases, including PKC. RPRD2 has been shown to function in the transcriptional regulation that can be influenced by PKC activity. Inhibiting PKC can therefore inhibit the transcriptional regulatory functions of RPRD2. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine selectively inhibits CDKs. By inhibiting CDK2, CDK7, and CDK9, it prevents the phosphorylation of substrates involved in transcription, which are necessary for RPRD2's coactivation function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI3Ks. It disrupts PI3K-dependent signaling pathways, which indirectly affects transcription factor activity and can inhibit RPRD2's role within these transcriptional processes. | ||||||
Indirubin-3′-monoxime | 160807-49-8 | sc-202660 sc-202660A sc-202660B | 1 mg 5 mg 50 mg | $79.00 $321.00 $671.00 | 1 | |
Indirubin-3'-monoxime is a CDK inhibitor that can inhibit the phosphorylation of transcription factors and other proteins that interact with RPRD2, leading to an inhibition of RPRD2's regulatory role in transcription. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). JNK is involved in transcription factor regulation, and its inhibition can disrupt signaling that would otherwise enable RPRD2 to modulate transcription. | ||||||